Apigenin: The Chamomile Compound That Protects NAD+, Promotes Sleep, and Supports Testosterone
Apigenin is better known as a component of chamomile tea. But at supplemental doses it also inhibits CD38 — the enzyme responsible for most age-related NAD+ decline — and modulates GABA-A receptors for sleep.
Apigenin: The Chamomile Compound That Protects NAD+, Promotes Sleep, and Supports Testosterone
Most people encounter apigenin as a footnote in chamomile tea research — a mild relaxant, maybe useful for winding down before bed. That picture is accurate, but it’s also radically incomplete.
Apigenin is a flavonoid found in chamomile, parsley, celery, and several other plants. It has sedative properties. It also inhibits an enzyme called CD38 that destroys NAD+ throughout your body. It weakly suppresses aromatase, the enzyme that converts testosterone into estrogen. And it modulates GABA-A receptors in a way that is mechanistically similar to — but meaningfully different from — benzodiazepines.
Andrew Huberman has mentioned apigenin in the context of his sleep stack. Peter Attia has discussed CD38 inhibition and NAD+ longevity. What neither has fully connected, in accessible writing, is that the same compound does all of these things at once — and that the interactions matter for how and when you take it.
This article covers all of it.
What Apigenin Actually Is
Apigenin (4′,5,7-trihydroxyflavone) belongs to the flavone subclass of flavonoids. It’s the primary bioactive in chamomile (Matricaria chamomilla), where it accounts for much of the plant’s documented effects. It also occurs in significant amounts in dried parsley, dried chamomile flowers, celery seed, and artichoke leaves.
As a supplement, it’s typically sold as an isolated extract, standardized to 50–100 mg per capsule. This is considerably more concentrated than what you’d get from chamomile tea, where a standard cup delivers roughly 0.5–5 mg depending on steep time and brand.
The reason isolated apigenin is worth discussing separately from chamomile tea is dose-dependent mechanism. At tea doses, you’re mostly getting mild anxiolytic and sleep-onset effects. At 50–100 mg, you start engaging the CD38 pathway and aromatase inhibition in ways that tea simply doesn’t reach.
The CD38 Connection: Why Apigenin Is a Longevity Compound
The NAD+ Decline Problem
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in hundreds of metabolic processes — mitochondrial energy production, DNA repair, sirtuin activation, and more. NAD+ levels decline substantially with age, and this decline is associated with reduced mitochondrial function, slower cellular repair, and increased disease risk.
Supplementing NAD+ precursors like NMN and NR (see our NMN vs NR deep-dive) has become a major area of longevity research. But there’s a second lever often overlooked: stopping NAD+ from being consumed in the first place.
What CD38 Does
CD38 is an enzyme that breaks down NAD+ as part of its signaling function. The problem is that CD38 expression increases with age and with inflammation (both of which tend to rise together). As CD38 activity goes up, NAD+ goes down.
A landmark 2016 paper by Camacho-Pereira et al. in Cell Metabolism demonstrated that CD38 is responsible for the majority of age-related NAD+ decline in mice. Mice with CD38 knocked out maintained youthful NAD+ levels and showed improved mitochondrial function well into old age.
This suggested an obvious intervention: inhibit CD38. Apigenin emerged as one of the most effective natural CD38 inhibitors tested.
The Evidence for Apigenin as a CD38 Inhibitor
The same Camacho-Pereira 2016 paper tested apigenin’s effects on CD38 activity in vivo. They found:
- Apigenin significantly inhibited CD38 activity in mouse liver and white adipose tissue
- Mice treated with apigenin showed increased NAD+ levels comparable to NMN supplementation
- Apigenin-treated mice showed improved glucose tolerance and reduced fat accumulation
The mechanisms are complementary to NMN/NR: NMN and NR increase NAD+ by providing more raw material; apigenin increases NAD+ by reducing its enzymatic destruction. This is why some researchers and longevity-focused clinicians now suggest combining a NAD+ precursor with a CD38 inhibitor.
The Sleep Mechanism: GABA-A Modulation
How It Works
Apigenin binds to benzodiazepine receptor sites on GABA-A receptors. GABA is the brain’s primary inhibitory neurotransmitter — when GABA-A receptors are activated, neural excitability decreases, producing anxiolytic and sedative effects.
Benzodiazepines (Valium, Xanax, Klonopin) work by the same mechanism, which explains why apigenin has similar but weaker effects. The critical difference is that benzodiazepines are full agonists at these sites — they strongly amplify GABA signaling. Apigenin appears to be a partial agonist, producing calming effects without the same degree of sedation, dependency risk, or next-day impairment.
Clinical Evidence for Sleep
A 2017 double-blind, placebo-controlled crossover study (Amsterdam et al., Phytomedicine) administered 270 mg of chamomile extract (standardized to 1.2% apigenin) to adults with generalized anxiety. Participants showed statistically significant reductions in Hamilton Anxiety Rating Scale scores compared to placebo, with effects sustained over 8 weeks.
For sleep specifically, a 2011 pilot RCT (Zick et al., BMC Complementary and Alternative Medicine) found that chamomile extract improved daytime functioning and subjective sleep quality in adults with chronic insomnia, though it did not significantly change total sleep time on polysomnography.
A 2017 RCT in elderly adults (Hieu et al.) found that chamomile extract significantly improved sleep quality scores (Pittsburgh Sleep Quality Index) compared to placebo over 28 days, with no adverse effects.
What the data shows collectively: apigenin reliably improves subjective sleep quality and reduces sleep onset time. It is not a sedative in the way that pharmaceutical sleep aids are — it won’t force you to sleep if you’re wired. It works better when combined with proper sleep hygiene and circadian rhythm support.
Apigenin vs. Melatonin for Sleep
These are mechanistically different and often stack well:
| Apigenin | Melatonin | |
|---|---|---|
| Mechanism | GABA-A modulation (calming) | Circadian signal (timing) |
| Primary effect | Reduces anxiety, aids sleep onset | Shifts sleep timing, mild sedation |
| Half-life | ~4 hours | 40–50 min (standard); varies by formulation |
| Optimal use | Anxiety-related insomnia, racing thoughts | Jet lag, phase shifting, travel |
| Dose-response | 50–100 mg typical | 0.5–1 mg is usually enough (see dosing guide) |
| Dependency risk | Very low | Low, but can blunt endogenous production |
For people whose sleep problem is “I can’t turn my brain off,” apigenin is often more effective than melatonin. For people who sleep fine once asleep but wake too early or have shifted rhythms, melatonin is the better fit.
The Testosterone Connection: Aromatase Inhibition
Aromatase is the enzyme that converts testosterone (and other androgens) into estrogens. In men especially, excess aromatase activity — particularly in adipose tissue — can shift the testosterone-to-estrogen ratio in an unfavorable direction, contributing to lower free testosterone, reduced libido, and mood changes.
Apigenin has demonstrated aromatase inhibitory effects in cell culture studies (Jeong et al., 1999, Journal of Steroid Biochemistry and Molecular Biology). The IC50 (concentration needed to inhibit 50% of aromatase activity) was measured at approximately 1.2 µM in vitro — meaningful but not as potent as pharmaceutical aromatase inhibitors.
No human RCTs have directly tested apigenin for testosterone optimization. However, this mechanism partially explains why apigenin is sometimes included in testosterone support stacks alongside Tongkat Ali and Ashwagandha — it may help preserve the testosterone-to-estrogen ratio while those compounds support testosterone production directly.
The evidence here is mechanistic, not clinical — worth noting but not overstating.
Apigenin and Inflammation: The NF-κB Pathway
Chronic low-grade inflammation (“inflammaging”) is a key driver of age-related decline. Apigenin consistently inhibits NF-κB, the master transcription factor that regulates pro-inflammatory cytokine expression (IL-1β, IL-6, TNF-α).
Multiple in vitro and animal studies have documented this effect: - Su et al. (2014, Journal of Immunology Research): apigenin reduced LPS-induced cytokine release in macrophages via NF-κB suppression - Sung et al. (2007, Anticancer Research): apigenin inhibited NF-κB activation in human cancer cell lines - Tordera et al. (2021): animal models showed reduced neuroinflammatory markers
The anti-inflammatory evidence in humans is limited to indirect markers and chamomile-based interventions rather than isolated apigenin trials. But the mechanism is consistent and well-characterized at the molecular level.
Dosing Protocol
General Guidance
| Use Case | Dose | Timing |
|---|---|---|
| Sleep / anxiolytic | 50 mg | 30–60 min before bed |
| NAD+ support / longevity | 50–100 mg | Morning or evening |
| Testosterone support stack | 50 mg | Any time; often in PM with other stack components |
| Stacked with NMN/NR | 50 mg | Same time as NAD+ precursor is fine |
Starting dose: 50 mg is the standard starting point. Most research and clinical use falls in the 50–100 mg range. Above 100 mg, there’s no well-studied advantage and the GABA-A effects may become more pronounced than desired.
Timing for sleep: Take 30–60 minutes before target sleep time. Apigenin doesn’t need to be cycled the way melatonin does, but some people find they habituate to the sedating effects over weeks; occasional breaks can help.
Timing for CD38/NAD+ support: Time of day is less critical for the CD38 mechanism. Morning is fine if you don’t want any sedative effect during the day; evening stacks conveniently with sleep benefits.
Bioavailability Considerations
Apigenin has moderate oral bioavailability, limited by poor water solubility and first-pass metabolism. Several strategies can improve absorption:
- Take with fat: Apigenin is lipophilic. A small amount of dietary fat (even a tablespoon of olive oil or a handful of nuts) improves absorption.
- Quercetin co-administration: Both are flavonoids metabolized by similar enzymes. Some evidence suggests they compete for the same metabolic pathways — taking separately may improve individual bioavailability.
- Black pepper / piperine: Piperine inhibits CYP1A2, one of the primary enzymes metabolizing apigenin, and may increase plasma concentrations. Evidence is indirect (based on quercetin data) but plausible.
Safety and Contraindications
Apigenin has a strong safety profile in the literature at doses up to 100 mg/day.
Known interactions: - Blood thinners (warfarin, aspirin therapy): Apigenin may have mild antiplatelet effects. Use caution if on anticoagulants — discuss with your physician. - Benzodiazepines and sedatives: Additive GABA-A effects. Do not combine with pharmaceutical sedatives without medical guidance. - CYP1A2 substrates: Apigenin is metabolized by and mildly inhibits CYP1A2. This enzyme also processes caffeine, theophylline, and some medications. High-dose apigenin may slightly slow metabolism of these compounds. - Hormone-sensitive conditions: The aromatase inhibitory and weak estrogenic effects (apigenin can act as a weak estrogen at some receptor subtypes) mean caution is warranted for anyone with hormone-sensitive cancers or on hormone therapy.
Pregnancy and breastfeeding: Insufficient safety data. Avoid.
Not a pharmaceutical sleep aid: Do not substitute apigenin for clinically prescribed sleep or anxiety medications without physician guidance.
What Examine.com and Healthline Miss
Most existing coverage of apigenin falls into one of two narrow boxes: chamomile tea research (underdosed, endpoints limited to anxiety) or cancer biology (in vitro studies, irrelevant doses). What’s missing from most sources:
- The CD38/NAD+ mechanism as a practical longevity intervention, not just a molecular curiosity
- The complementarity with NMN/NR — they work by different mechanisms and may stack
- The testosterone-support angle — mechanistically grounded even without direct human RCTs
- The dose distinction between chamomile tea and isolated apigenin supplementation
- Practical stacking guidance combining sleep + longevity goals without redundancy
The compound is more than a chamomile derivative. For anyone already thinking about NAD+ optimization (see NMN vs NR), adding a CD38 inhibitor is a logical next step — and apigenin is the most accessible and best-studied option available.
Summary
- Primary mechanisms: GABA-A modulation (sleep), CD38 inhibition (NAD+ preservation), aromatase inhibition (testosterone support), NF-κB suppression (anti-inflammation)
- Strongest evidence for: Sleep quality improvement, anxiety reduction
- Mechanistic evidence for: NAD+ preservation via CD38 inhibition, aromatase suppression
- Standard dose: 50 mg (sleep/anxiolytic) to 100 mg (longevity stack)
- Safety: Well-tolerated at studied doses; interaction cautions with blood thinners and sedatives
- Best stacked with: NMN or NR for comprehensive NAD+ strategy; Tongkat Ali + Ashwagandha for testosterone support; sleep hygiene fundamentals for sleep optimization
Apigenin is one of the more unusual compounds in the supplement space — a molecule that meaningfully participates in sleep, longevity, and hormonal health simultaneously, with a good safety profile and a reasonable evidence base. That combination is rarer than it sounds.
